No evidence for involvement of the human inducible nitric oxide synthase gene in susceptibility to coronary artery disease [1]

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 2, 2005, Pages 253-255

  Muntwyler, Jörg ^a   Marti Jaun, Jacqueline ^b   Lüscher, Thomas F ^a   Hänseler, Edgar ^b   Hersberger, Martin ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Atherosclerosis; Gene; Nitric oxide synthase; Polymorphism; Risk factor

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDUCIBLE NITRIC OXIDE SYNTHASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ATHEROGENESIS; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GENE DELETION; GENE FREQUENCY; GENE FUNCTION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LETTER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SMOKING;

BASE SEQUENCE; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; DISEASE SUSCEPTIBILITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; HUMANS; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; POLYMORPHISM, GENETIC; RISK FACTORS; TANDEM REPEAT SEQUENCES;

EID: 14944363035     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2005.042     Document Type: Letter

References (16)

1. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell 2001;104:503-16.
2. Drexler H. Nitric oxide and coronary endothelial dysfunction in humans. Cardiovasc Res 1999;43:572-9.
3. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995;375:408-11.
4. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Chdstov VI, et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1995;274:1917-21.
5. Brown GC, Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 2003;27:325-55.
6. Chisolm GM III, Hazen SL, Fox PL, Cathcart MK. The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms. J Biol Chem 1999;274:25959-62.
7. Lirk P, Hoffmann G, Rieder J. Inducible nitric oxide synthase - time for reappralsal. Curr Drug Targets Inflamm Allergy 2002;1:89-108.
8. Cromheeke KM, Kockx MM, De Meyer GR, Bosmans JM, Bult H, Beelaerts W J, et al. Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques. Cardiovasc Res 1999;43:744-54.
9. Depre C, Havaux X, Renkin J, Vanoverschelde JL, Wijns W. Expression of inducible nitric oxide synthase in human coronary atherosclerotic plaque. Cardiovasc Res 1999;41:465-72.
10. Behr D, Rupin A, Fabiani JN, Verbeuren TJ. Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits. Atherosclerosis 1999;142:335-44.
11. Morris B J, Markus A, Glenn CL, Adams DJ, Colagiuri S, Wang L. Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes. J Mol Med 2002;80:96-104.
12. Warpeha KM, Xu W, Liu L, Charles IG, Patterson CC, AhFat F, et al. Genotyping and functional analysis of a polymorphic (CCTTT)(n) repeat of NOS2A in diabetic retinopathy. FASEB J 1999;13:1825-32.
13. Johannesen J, Tarnow L, Parving HH, Nerup J, Pociot F. CCTTT-repeat polymorphism in the human NOS2-promoter confers low risk of diabetic nephropathy in type 1 diabetic patients. Diabetes Care 2000;23:560-2.
14. Morris BJ, Glenn CL, Wilcken DE, Wang XL. Influence of an inducible nitric oxide synthase promoter variant on clinical variables in patients with coronary artery disease. Clin Sci (Lond) 2001;100:551-6.
15. Hersberger M, Bonhoeffer S, Rampini SK, Opravil M, Marti-Jaun J, Telenti A, et al. CCTTT-repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesis. Clin Exp Immunol 2004;137:566-9.
16. Kunnas TA, Mikkelsson J, Ilveskoski E, Tanner MM, Laippala P, Penttila A, et al. A functional variant of the iNOS gene flanking region is associated with LAD coronary artery disease: an autopsy study. Eur J Clin Invest 2003;33:1032-7.